Please ensure Javascript is enabled for purposes of website accessibility

Why Novavax Stock Is Sinking Today

By Keith Speights - Sep 4, 2020 at 10:20AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The overall market sell-off is dragging down the biotech.

What happened

Shares of Novavax (NVAX 2.80%) were sinking 12.3% as of 11:06 a.m. EDT on Friday. The steep decline didn't stem from any negative development for the biotech but instead appeared to be caused by the overall stock market sell-off.

So what

What does the big drop for the biotech stock today mean for investors? At worst, nothing. At best, an opportunity to buy Novavax at a cheaper price.

Scientist holding syringe and vaccine bottle

Image source: Getty Images.

Most stocks fall when the overall market falls significantly (and rise when the market rises significantly). Those gyrations, though, often have no connection whatsoever with the individual stocks' prospects. That's definitely the case with Novavax.

How the economy is doing or what the latest jobless numbers are really don't matter for Novavax. What's most important for the biotech is how its COVID-19 vaccine candidate NVX‑CoV2373 performs in clinical testing.

So far, the story on this front is a good one. Novavax announced on Thursday that The New England Journal of Medicine published additional details from a phase 1 study of the experimental vaccine. The new data looked as promising as earlier results.

Now what

Novavax's shares could continue to be highly volatile, especially if the stock market remains choppy. The main thing to watch, though, is the progress of its phase 2 study evaluating NVX‑CoV2373. The company expects to report interim results in the fourth quarter of this year.

Keith Speights has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Novavax, Inc. Stock Quote
Novavax, Inc.
NVAX
$41.47 (2.80%) $1.13

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
400%
 
S&P 500 Returns
128%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 08/13/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.